Phillips 66 Reports Fourth-Quarter 2021 Financial Results
Fourth Quarter Reported fourth-quarter earnings of $1.3 billion or $2.88 per share; adjusted earnings of…
News
Schlumberger DELFI Digital Platform Selected by Northern Lights JV for CO2 Project
The Northern Lights joint venture between Equinor, Shell, and TotalEnergies will use the DELFI environment…
Schlumberger DELFI Digital Platform Selected by Northern Lights JV for CO2 Project
The Northern Lights joint venture between Equinor, Shell, and TotalEnergies will use the DELFI environment…
Okta Appoints Brett Tighe as Chief Financial Officer
SAN FRANCISCO–(BUSINESS WIRE)–Okta, Inc. (Nasdaq: OKTA), the leading independent identity provider, today announced that Brett…
Church & Dwight Reports Fourth Quarter and Full Year 2021 Results
2021 Fourth Quarter Results Net Sales growth +5.7%: Domestic +5.1%, Int’l +5.9%, SPD 12% Organic…
VF Reports Third Quarter Fiscal 2022 Results; Reaffirms Full Year Fiscal 2022 Earnings Outlook
Revenue from continuing operations increased 22 percent (up 22 percent in constant dollars) to $3.6…
NuStar Energy L.P. Declares Fourth Quarter 2021 Common Unit Distribution and Series A, Series B and Series C Preferred Units Distributions
SAN ANTONIO–(BUSINESS WIRE)–NuStar Energy L.P. (NYSE: NS) today announced that its Board of Directors has…
TPG RE Finance Trust, Inc. Announces CEO Appointment
Incoming CEO Doug Bouquard also named Partner of TPG NEW YORK–(BUSINESS WIRE)–TPG RE Finance Trust,…
DocGo Announces Record Preliminary Fourth Quarter 2021 Revenue
Full year and fourth quarter revenue of $305.0 million and $107.8 million, respectively, more than…
Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies
KENILWORTH, N.J. & MIAMI–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States…
Dataiku Expands UK Team With Appointment of Simone Larsson, AI Evangelist
The leading AI unicorn welcomes former Accenture and Digital Catapult senior AI strategist to its…
Oxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into a newly formed AAV Manufacturing and Innovation Business in the US with Homology Medicines as 20% owner
Oxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into…
Oxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into a newly formed AAV Manufacturing and Innovation Business in the U.S. with Homology Medicines as 20% owner
Oxford Biomedica and Homology Medicines to establish Oxford Biomedica Solutions LLC, a new U.S.-based AAV…
Blue Danube Systems Enters Agreement to Be Acquired by NEC Corporation
SANTA CLARA, Calif.–(BUSINESS WIRE)–Blue Danube Systems, a provider of intelligent wireless access solutions that help…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of GWG Holdings, Inc. (GWGH) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
US Metro Bancorp Announces Fourth Quarter and Full Year 2021 Results
230% INCREASE IN EARNINGS YTD 2021 OVER YTD 2020 ROAA 1.72% for Twelve Months ROAE…
Loan Originations Highlight TFS Financial Corporation First Quarter Results
CLEVELAND–(BUSINESS WIRE)–TFS Financial Corporation (NASDAQ: TFSL) (the “Company”), the holding company for Third Federal Savings…
Biogen Reaches Agreement with Samsung Biologics to Sell Equity Stake in Their Biosimilar Joint Venture for up to $2.3 billion
The companies will continue with their exclusive agreements, including for commercialization of their current portfolio…
ALX Oncology Receives U.S. FDA Orphan Drug Designation for Evorpacept for the Treatment of Patients with Gastric Cancer and Gastroesophageal Junction Cancer
SOUTH SAN FRANCISCO, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX…
Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus
MELBOURNE, Australia and ATHENS, Greece, Jan. 28, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…